Metabolic acidosis increases fibroblast growth factor 23 in neonatal mouse bone
- PMID: 22647635
- PMCID: PMC3433868
- DOI: 10.1152/ajprenal.00199.2012
Metabolic acidosis increases fibroblast growth factor 23 in neonatal mouse bone
Abstract
Fibroblast growth factor 23 (FGF23) significantly increases with declining renal function, leading to reduced renal tubular phosphate reabsorption, decreased 1,25-dihydroxyvitamin D, and increased left ventricular hypertrophy. Elevated FGF23 is associated with increased mortality. FGF23 is synthesized in osteoblasts and osteocytes; however, the mechanisms by which it is regulated are not clear. Patients with chronic kidney disease have decreased renal acid excretion leading to metabolic acidosis, which has a direct effect on bone cell activity. We hypothesized that metabolic acidosis would directly increase bone cell FGF23 production. Using cultured neonatal mouse calvariae, we found that metabolic acidosis increased medium FGF23 protein levels as well as FGF23 RNA expression at 24 h and 48 h compared with incubation in neutral pH medium. To exclude that the increased FGF23 was secondary to metabolic acidosis-induced release of bone mineral phosphate, we cultured primary calvarial osteoblasts. In these cells, metabolic acidosis increased FGF23 RNA expression at 6 h compared with incubation in neutral pH medium. Thus metabolic acidosis directly increases FGF23 mRNA and protein in mouse bone. If these results are confirmed in humans with chronic kidney disease, therapeutic interventions to mitigate acidosis, such as bicarbonate administration, may also lower levels of FGF23, decrease left ventricular hypertrophy, and perhaps even decrease mortality.
Figures





Similar articles
-
Biology of Fibroblast Growth Factor 23: From Physiology to Pathology.Cold Spring Harb Perspect Med. 2018 May 1;8(5):a031260. doi: 10.1101/cshperspect.a031260. Cold Spring Harb Perspect Med. 2018. PMID: 28778965 Free PMC article. Review.
-
Stimulation of fibroblast growth factor 23 by metabolic acidosis requires osteoblastic intracellular calcium signaling and prostaglandin synthesis.Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F882-F886. doi: 10.1152/ajprenal.00522.2016. Epub 2017 Mar 15. Am J Physiol Renal Physiol. 2017. PMID: 28298360 Free PMC article.
-
Regulation of COX-2 mediates acid-induced bone calcium efflux in vitro.J Bone Miner Res. 2007 Jun;22(6):907-17. doi: 10.1359/jbmr.070316. J Bone Miner Res. 2007. PMID: 17352658
-
Chronic acidosis-induced alteration in bone bicarbonate and phosphate.Am J Physiol Renal Physiol. 2003 Sep;285(3):F532-9. doi: 10.1152/ajprenal.00128.2003. Epub 2003 May 20. Am J Physiol Renal Physiol. 2003. PMID: 12759230
-
Cellular mechanisms of bone resorption induced by metabolic acidosis.Semin Dial. 2003 Nov-Dec;16(6):463-6. doi: 10.1046/j.1525-139x.2003.16100.x. Semin Dial. 2003. PMID: 14629607 Review.
Cited by
-
Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients.Eur J Med Res. 2018 Apr 17;23(1):18. doi: 10.1186/s40001-018-0315-z. Eur J Med Res. 2018. PMID: 29665846 Free PMC article.
-
Oral Acid Load Down-Regulates Fibroblast Growth Factor 23.Nutrients. 2022 Feb 28;14(5):1041. doi: 10.3390/nu14051041. Nutrients. 2022. PMID: 35268016 Free PMC article.
-
Biology of Fibroblast Growth Factor 23: From Physiology to Pathology.Cold Spring Harb Perspect Med. 2018 May 1;8(5):a031260. doi: 10.1101/cshperspect.a031260. Cold Spring Harb Perspect Med. 2018. PMID: 28778965 Free PMC article. Review.
-
Phosphate Binding with Sevelamer Preserves Mechanical Competence of Bone Despite Acidosis in Advanced Experimental Renal Insufficiency.PLoS One. 2016 Sep 22;11(9):e0163022. doi: 10.1371/journal.pone.0163022. eCollection 2016. PLoS One. 2016. PMID: 27658028 Free PMC article.
-
Changes in Fibroblast Growth Factor 23 and Soluble Klotho Levels After Hemodialysis Initiation.Kidney Med. 2019 Dec 4;2(1):59-67. doi: 10.1016/j.xkme.2019.09.007. eCollection 2020 Jan-Feb. Kidney Med. 2019. PMID: 33015612 Free PMC article.
References
-
- Anderson PH, Atkins GJ. The skeleton as an intracrine organ for vitamin D metabolism. Mol Aspects Med 29: 397–406, 2008 - PubMed
-
- Bushinsky DA, Lechleider RJ. Mechanism of proton-induced bone calcium release: calcium carbonate-dissolution. Am J Physiol Renal Fluid Electrolyte Physiol 253: F998–F1005, 1987 - PubMed
-
- Bushinsky DA, Wolbach W, Sessler NE, Mogilevsky R, Levi-Setti R. Physicochemical effects of acidosis on bone calcium flux and surface ion composition. J Bone Miner Res 8: 93–102, 1993 - PubMed
-
- Cancela AL, Oliveira RB, Graciolli FG, dos Reis LM, Barreto F, Barreto DV, Cuppari L, Jorgetti V, Carvalho AB, Canziani ME, Moyses RM. Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate. Nephron Clin Pract 117: 74–82, 2011 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases